UBS Group’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.22M | Buy |
377,447
+16,128
| +4% | +$94.8K | ﹤0.01% | 3742 |
|
|
2025
Q1 | $3.03M | Sell |
361,319
-607,115
| -63% | -$5.09M | ﹤0.01% | 3389 |
|
|
2024
Q4 | $7.21M | Buy |
968,434
+892,456
| +1,175% | +$6.64M | ﹤0.01% | 2649 |
|
|
2024
Q3 | $441K | Buy |
75,978
+35,959
| +90% | +$209K | ﹤0.01% | 4184 |
|
|
2024
Q2 | $266K | Sell |
40,019
-44,684
| -53% | -$297K | ﹤0.01% | 4362 |
|
|
2024
Q1 | $1.11M | Buy |
84,703
+32,904
| +64% | +$429K | ﹤0.01% | 3483 |
|
|
2023
Q4 | $660K | Buy |
51,799
+51,674
| +41,339% | +$659K | ﹤0.01% | 3755 |
|
|
2023
Q3 | $1.64K | Sell |
125
-33,199
| -100% | -$435K | ﹤0.01% | 6726 |
|
|
2023
Q2 | $852K | Buy |
33,324
+19,179
| +136% | +$491K | ﹤0.01% | 3429 |
|
|
2023
Q1 | $356K | Buy |
14,145
+8,039
| +132% | +$203K | ﹤0.01% | 3939 |
|
|
2022
Q4 | $140K | Buy |
6,106
+4,664
| +323% | +$107K | ﹤0.01% | 4673 |
|
|
2022
Q3 | $32K | Buy |
1,442
+637
| +79% | +$14.1K | ﹤0.01% | 5720 |
|
|
2022
Q2 | $11K | Buy |
805
+705
| +705% | +$9.63K | ﹤0.01% | 6810 |
|
|
2022
Q1 | $2K | Sell |
100
-9,435
| -99% | -$189K | ﹤0.01% | 8615 |
|
|
2021
Q4 | $178K | Buy |
9,535
+9,311
| +4,157% | +$174K | ﹤0.01% | 4751 |
|
|
2021
Q3 | $6K | Sell |
224
-251
| -53% | -$6.72K | ﹤0.01% | 7301 |
|
|
2021
Q2 | $15K | Buy |
+475
| New | +$15K | ﹤0.01% | 6552 |
|